Kayesh Mohammad Enamul Hoque, Kohara Michinori, Tsukiyama-Kohara Kyoko
Department of Microbiology and Public Health, Faculty of Animal Science and Veterinary Medicine, Patuakhali Science and Technology University, Barishal 8210, Bangladesh.
Transboundary Animal Diseases Center, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima 890-0065, Japan.
Vaccines (Basel). 2025 Jul 15;13(7):754. doi: 10.3390/vaccines13070754.
Powassan virus is an emerging tick-borne flavivirus that poses a significant threat to human health. The outcome of Powassan virus infection is shaped by both viral factors and the host immune response. While this review aimed to examine the innate immune response, particularly toll-like receptor-mediated immune responses to Powassan virus, data specific to the immune response to Powassan virus remain scarce. Therefore, we focused on toll-like receptor responses to related flaviviruses to infer possible mechanisms of host response. Insights from both in vivo and in vitro studies are critical for guiding the development of effective therapeutic and preventive strategies. Currently, there are no clinically approved treatments or vaccines for Powassan virus, highlighting the urgent need for their development. We also highlight recent progress in POWV vaccine development, with an emphasis on the potential use of toll-like receptor agonists as adjuvants to enhance immunogenicity and improve vaccine efficacy.
波瓦桑病毒是一种新出现的蜱传黄病毒,对人类健康构成重大威胁。波瓦桑病毒感染的结果由病毒因素和宿主免疫反应共同决定。虽然本综述旨在研究固有免疫反应,特别是Toll样受体介导的对波瓦桑病毒的免疫反应,但关于对波瓦桑病毒免疫反应的具体数据仍然匮乏。因此,我们聚焦于对相关黄病毒的Toll样受体反应,以推断宿主反应的可能机制。体内和体外研究的见解对于指导有效治疗和预防策略的开发至关重要。目前,尚无针对波瓦桑病毒的临床批准治疗方法或疫苗,这凸显了开发它们的迫切需求。我们还强调了波瓦桑病毒疫苗开发的最新进展,重点是Toll样受体激动剂作为佐剂增强免疫原性和提高疫苗效力的潜在用途。